Nadav Friedmann
Plus aucun poste en cours
Profil
Nadav Friedmann served as President & Chief Executive Officer at DaIIchi Pharma Holdings, Inc. from 1997 to 2000.
He also worked as Vice President at Johnson & Johnson from 1980 to 1991 and as Vice President-Clinical Research at XOMA Corp.
from 1992 to 1995.
He was the Director, Chief Operating & Medical Officer at Cassava Sciences, Inc. from 1998 to 2022.
Dr. Friedmann also served as Medical Director at Abbott Laboratories.
He was an Advisor at Presidio Partners and President & Owner at Emet Research, Inc. Dr. Friedmann holds a doctorate degree from the University of California San Diego and Albert Einstein College of Medicine, Inc.
Anciens postes connus de Nadav Friedmann
Sociétés | Poste | Fin |
---|---|---|
CASSAVA SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 20/12/2022 |
Emet Research, Inc. | President | 20/12/2022 |
DaIIchi Pharma Holdings, Inc. | Chief Executive Officer | 01/04/2000 |
XOMA CORPORATION | Chief Tech/Sci/R&D Officer | 01/01/1995 |
JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/1991 |
Formation de Nadav Friedmann
University of California San Diego | Doctorate Degree |
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
ABBOTT LABORATORIES | Health Technology |
JOHNSON & JOHNSON | Health Technology |
XOMA CORPORATION | Health Technology |
CASSAVA SCIENCES, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Presidio Partners
Presidio Partners Investment ManagersFinance Presidio Partners is a venture capital firm founded in the year 1989 by Thomas R. Baruch. The firm is headquartered in San Francisco, California. | Finance |
Emet Research, Inc. | |
DaIIchi Pharma Holdings, Inc. |